Wen-Wei Feng

Dr. Wen-Wei Feng

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
Wen-Wei FengWen-Wei Feng
Wen-Wei Feng
QTQuan Minh Tran
Quan Minh Tran
CLChuan-Yuan Lin
Chuan-Yuan Lin
JLJui-Yu Lin
Jui-Yu Lin
HCHsiu-Chao Chen
Hsiu-Chao Chen
Chung-Der HsiaoChung-Der Hsiao
Chung-Der Hsiao
Wound healing research has advanced with biodegradable polymers as a promising treatment, especially for chronic wounds. Zebrafish offer a cost-effective, regenerative, and human-relevant model for real-time, reproducible skin repair studies. The primary objective of this study is to investigate the efficacy of biodegradable polymers, PLLA (poly-l-lactic acid) and PDLLA (poly-D, L lactic acid), in promoting skin wound healing in zebrafish, while understanding their mechanisms of action at the cellular and molecular levels. Using a laser-based ablation method, which provides precision and reproducibility, skin wounds are created in zebrafish and treated with these polymers to test their wound closure-promoting efficacy. The healing process was monitored by capturing the dynamic change of skin wound size and further analyzed through molecular techniques to evaluate key biomarker genes that are important for collagen deposition, angiogenesis, and inflammation. Additionally, a comprehensive biosafety assessment of PDLLA and PLLA is conducted to ensure their biocompatibility and safety for therapeutic applications. Results showed that usage of PLLA and PDLLA, especially when they were combined, significantly enhanced the wound healing process in zebrafish. Overall, this study highlighted the effectiveness of PLLA and PDLLA in enhancing skin wound healing, providing valuable insights into their mechanisms and paving the way for future research and clinical applications in human wound care.

1 July 2006 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
Wen-Wei FengWen-Wei Feng
Wen-Wei Feng
HCHsiu-Chao Chen
Hsiu-Chao Chen
HCHung-Chi Chen
Hung-Chi Chen
A 3-year-old boy presented with a 15 x 15-cm papulonodular lesion on his left shin of 8 weeks' duration. The lesion was considered a Majocchi's granuloma caused by Trichophyton tonsurans. He was treated with griseofulvin and topical clotrimazole and hydrocortisone cream and responded well after 8 weeks of treatment.

10 February 2024 in Biology
Verified
Journal Article
Open access
PDF file
Wen-Wei FengWen-Wei Feng
Wen-Wei Feng
HCHsiu-Chao Chen
Hsiu-Chao Chen
GAGilbert Audira
Gilbert Audira
MSMichael Edbert Suryanto
Michael Edbert Suryanto
Ferry SaputraFerry Saputra
Ferry Saputra
CHChih-Hsin Hung
Chih-Hsin Hung
Tacrolimus (FK506) is a common immunosuppressant that is used in organ transplantation. However, despite its importance in medical applications, it is prone to adverse side effects. While some studies have demonstrated its toxicities to humans and various animal models, very few studies have addressed this issue in aquatic organisms, especially zebrafish. Here, we assessed the adverse effects of acute and chronic exposure to tacrolimus in relatively low doses in zebrafish in both larval and adult stages, respectively. Based on the results, although tacrolimus did not cause any cardiotoxicity and respiratory toxicity toward zebrafish larvae, it affected their locomotor activity performance in light–dark locomotion tests. Meanwhile, tacrolimus was also found to slightly affect the behavior performance, shoaling formation, circadian rhythm locomotor activity, and color preference of adult zebrafish in a dose-dependent manner. In addition, alterations in the cognitive performance of the fish were also displayed by the treated fish, indicated by a loss of short-term memory. To help elucidate the toxicity mechanism of tacrolimus, molecular docking was conducted to calculate the strength of the binding interaction between tacrolimus to human FKBP12. The results showed a relatively normal binding affinity, indicating that this interaction might only partly contribute to the observed alterations. Nevertheless, the current research could help clinicians and researchers to further understand the toxicology of tacrolimus, especially to zebrafish, thus highlighting the importance of considering the toxicity of tacrolimus prior to its usage.